Moreno, C, Montillo, M, Panayiotidis, P, Dimou, M, Bloor, A, Dupuis, J, Schuh, A, Norin, S, Geisler, C, Hillmen, P, Doubek, M, Trněný, M, Obrtlikova, P
, Laurenti, L, Stilgenbauer, S, Smolej, L, Ghia, P, Cymbalista, F, Jaeger, U, Stamatopoulos, K, Stavroyianni, N, Carrington, P, Zouabi, H, Leblond, V, JC, G-G, Rubio, M, Marasca, R, Musuraca, G, Rigacci, L, Farina, L, Paolini, R, Pospisilova, S, Kimby, E, Bradley, C & Montserrat, E 2015, '
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.',
Haematologica, vol. 100, n. 4, pagg. 511-516.
https://doi.org/10.3324/haematol.2014.118158